Skip to main content

Table 2 The neutralization potencies of YG8–1, YG8–2, and YG8–3 toward rabbit RBCs treated with HlgAB and HlgBC. IC50 expressed as mAb:toxin ratio

From: Novel human monoclonal antibodies targeting the F subunit of leukocidins reduce disease progression and mortality caused by Staphylococcus aureus

toxin HlgAB HlgBC
mAbs
YG8–1 0.10 0.28
YG8–2 0.12 0.27
YG8–3 0.26 0.21